NHPAP
Price
$18.12
Change
+$0.03 (+0.17%)
Updated
Sep 5 closing price
Capitalization
N/A
88 days until earnings call
PSA
Price
$297.80
Change
+$5.58 (+1.91%)
Updated
Sep 5 closing price
Capitalization
52.25B
58 days until earnings call
Interact to see
Advertisement

NHPAP vs PSA

Header iconNHPAP vs PSA Comparison
Open Charts NHPAP vs PSABanner chart's image
National Healthcare Properties
Price$18.12
Change+$0.03 (+0.17%)
Volume$4.23K
CapitalizationN/A
Public Storage
Price$297.80
Change+$5.58 (+1.91%)
Volume$595.05K
Capitalization52.25B
NHPAP vs PSA Comparison Chart in %
Loading...
NHPAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NHPAP vs. PSA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NHPAP is a StrongBuy and PSA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (NHPAP: $18.12 vs. PSA: $297.80)
Brand notoriety: NHPAP and PSA are both not notable
NHPAP represents the Managed Health Care, while PSA is part of the Miscellaneous Manufacturing industry
Current volume relative to the 65-day Moving Average: NHPAP: 35% vs. PSA: 75%
Market capitalization -- NHPAP: $0 vs. PSA: $52.25B
NHPAP [@Managed Health Care] is valued at $0. PSA’s [@Miscellaneous Manufacturing] market capitalization is $52.25B. The market cap for tickers in the [@Managed Health Care] industry ranges from $116.34B to $0. The market cap for tickers in the [@Miscellaneous Manufacturing] industry ranges from $105.47B to $0. The average market capitalization across the [@Managed Health Care] industry is $8.71B. The average market capitalization across the [@Miscellaneous Manufacturing] industry is $8.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NHPAP’s FA Score shows that 1 FA rating(s) are green whilePSA’s FA Score has 1 green FA rating(s).

  • NHPAP’s FA Score: 1 green, 4 red.
  • PSA’s FA Score: 1 green, 4 red.
According to our system of comparison, PSA is a better buy in the long-term than NHPAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NHPAP’s TA Score shows that 3 TA indicator(s) are bullish while PSA’s TA Score has 6 bullish TA indicator(s).

  • NHPAP’s TA Score: 3 bullish, 5 bearish.
  • PSA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PSA is a better buy in the short-term than NHPAP.

Price Growth

NHPAP (@Managed Health Care) experienced а +0.81% price change this week, while PSA (@Miscellaneous Manufacturing) price change was +1.09% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +2.07%. For the same industry, the average monthly price growth was +5.46%, and the average quarterly price growth was +13.10%.

The average weekly price growth across all stocks in the @Miscellaneous Manufacturing industry was +0.43%. For the same industry, the average monthly price growth was +3.96%, and the average quarterly price growth was +6.08%.

Reported Earning Dates

NHPAP is expected to report earnings on Dec 03, 2025.

PSA is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Managed Health Care (+2.07% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

@Miscellaneous Manufacturing (+0.43% weekly)

Miscellaneous manufacturing refers to a diverse range of products that cannot readily be categorized into other specific sectors of manufacturing. Major U.S. players in this industry include AMETEK, Inc.( analytical instruments, precision components and specialty materials), Dover Corporation (solutions for efficiency and safety of extracting oil and gas, e.g. rod lifts, progressing cavity pumps, gas lifts etc.; solutions for the transportation/transformation of solid waste; products for safe handling of critical fluids for various industries; systems for commercial-refrigeration, heating and cooling, and food and beverage packaging), and Carlisle Companies Incorporated (niche markets including commercial roofing, energy, lawn and garden, mining and construction equipment, aerospace and electronics, dining and food delivery, and healthcare), among others.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NHPAP YTD gains are higher at: 34.609 vs. PSA (1.459). PSA has higher annual earnings (EBITDA): 3.25B vs. NHPAP (69.3M). PSA has more cash in the bank: 1.11B vs. NHPAP (47.1M). NHPAP has less debt than PSA: NHPAP (1.04B) vs PSA (10.4B). PSA has higher revenues than NHPAP: PSA (4.75B) vs NHPAP (348M).
NHPAPPSANHPAP / PSA
CapitalizationN/A52.2B-
EBITDA69.3M3.25B2%
Gain YTD34.6091.4592,371%
P/E RatioN/A31.87-
Revenue348M4.75B7%
Total Cash47.1M1.11B4%
Total Debt1.04B10.4B10%
FUNDAMENTALS RATINGS
PSA: Fundamental Ratings
PSA
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
31
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NHPAPPSA
RSI
ODDS (%)
Bearish Trend 1 day ago
31%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 1 day ago
58%
Declines
ODDS (%)
Bearish Trend 8 days ago
46%
Bearish Trend 11 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
36%
Bearish Trend 1 day ago
48%
Aroon
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
NHPAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.090.02
+1.87%
Lexicon Pharmaceuticals
HI26.230.46
+1.79%
Hillenbrand
MDGL432.891.68
+0.39%
Madrigal Pharmaceuticals
CUBWU10.65N/A
N/A
Lionheart Holdings
GNTA3.50N/A
N/A
Genenta Science SpA

NHPAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NHPAP has been loosely correlated with EXR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NHPAP jumps, then EXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NHPAP
1D Price
Change %
NHPAP100%
+0.13%
EXR - NHPAP
33%
Loosely correlated
+2.39%
CUBE - NHPAP
31%
Poorly correlated
+1.85%
PCH - NHPAP
31%
Poorly correlated
+1.59%
STAG - NHPAP
31%
Poorly correlated
+0.54%
PSA - NHPAP
30%
Poorly correlated
+1.91%
More